The pathogenesis and treatment mechanism of Parkinson's disease from the perspective of traditional Chinese medicine.


Journal

Phytomedicine : international journal of phytotherapy and phytopharmacology
ISSN: 1618-095X
Titre abrégé: Phytomedicine
Pays: Germany
ID NLM: 9438794

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 18 10 2021
revised: 26 02 2022
accepted: 11 03 2022
pubmed: 27 3 2022
medline: 27 4 2022
entrez: 26 3 2022
Statut: ppublish

Résumé

Parkinson's disease (PD) is the second most common neurodegenerative disease with no treatment currently available to modify its progression. Traditional Chinese medicine (TCM) has gained attention for its unique theoretical basis and clinical effects. Many studies have reported on the clinical effects and pharmacological mechanisms of Chinese herbs in PD. However, few studies have focused on the treatment mechanisms of anti-PD TCM drugs from the perspective of TCM itself. To elaborate the treatment mechanisms of anti-PD TCM drugs in the perspective of TCM. We performed a literature survey using traditional books of Chinese medicine and online scientific databases including PubMed, Web of Science, Google Scholar, China National Knowledge Infrastructure (CNKI), and others up to July 2021. TCM theory states that PD is caused by a dysfunction of the zang-fu organs (liver, spleen, kidney, and lung) and subsequent pathogenic factors (wind, fire, phlegm, and blood stasis). Based on the pathogenesis, removing pathogenic factors and restoring visceral function are two primary treatment principles for PD in TCM. The former includes dispelling wind, clearing heat, resolving phlegm, and promoting blood circulation, while the latter involves nourishing the liver and kidney and strengthening the spleen. The anti-PD mechanisms of the active ingredients of TCM compounds and herbs at different levels include anti-apoptosis, anti-inflammation, and anti-oxidative stress, as well as the restoration of mitochondrial function and the regulation of autophagy and neurotransmitters. Chinese herbs and prescriptions can be used to treat PD by targeting multiple pharmacological mechanisms.

Sections du résumé

BACKGROUND BACKGROUND
Parkinson's disease (PD) is the second most common neurodegenerative disease with no treatment currently available to modify its progression. Traditional Chinese medicine (TCM) has gained attention for its unique theoretical basis and clinical effects. Many studies have reported on the clinical effects and pharmacological mechanisms of Chinese herbs in PD. However, few studies have focused on the treatment mechanisms of anti-PD TCM drugs from the perspective of TCM itself.
PURPOSE OBJECTIVE
To elaborate the treatment mechanisms of anti-PD TCM drugs in the perspective of TCM.
METHODS METHODS
We performed a literature survey using traditional books of Chinese medicine and online scientific databases including PubMed, Web of Science, Google Scholar, China National Knowledge Infrastructure (CNKI), and others up to July 2021.
RESULTS RESULTS
TCM theory states that PD is caused by a dysfunction of the zang-fu organs (liver, spleen, kidney, and lung) and subsequent pathogenic factors (wind, fire, phlegm, and blood stasis). Based on the pathogenesis, removing pathogenic factors and restoring visceral function are two primary treatment principles for PD in TCM. The former includes dispelling wind, clearing heat, resolving phlegm, and promoting blood circulation, while the latter involves nourishing the liver and kidney and strengthening the spleen. The anti-PD mechanisms of the active ingredients of TCM compounds and herbs at different levels include anti-apoptosis, anti-inflammation, and anti-oxidative stress, as well as the restoration of mitochondrial function and the regulation of autophagy and neurotransmitters.
CONCLUSION CONCLUSIONS
Chinese herbs and prescriptions can be used to treat PD by targeting multiple pharmacological mechanisms.

Identifiants

pubmed: 35338993
pii: S0944-7113(22)00122-2
doi: 10.1016/j.phymed.2022.154044
pii:
doi:

Substances chimiques

Drugs, Chinese Herbal 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

154044

Informations de copyright

Copyright © 2022. Published by Elsevier GmbH.

Auteurs

Peng Chen (P)

Basic Medical School, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China; Accreditation Center of Traditional Chinese Medicine Physician, National Administration of Traditional Chinese Medicine, Beijing, China. Electronic address: 740466982@qq.com.

Jie Zhang (J)

Basic Medical School, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.

Chen Wang (C)

Department of Traditional Chinese Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China.

Yi-Hui Chai (YH)

Basic Medical School, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.

An-Guo Wu (AG)

School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China.

Ning-Yu Huang (NY)

Accreditation Center of Traditional Chinese Medicine Physician, National Administration of Traditional Chinese Medicine, Beijing, China. Electronic address: 13691556254@139.com.

Long Wang (L)

School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China. Electronic address: wanglongsdu1226@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH